Galena Biopharma fka GALE

[Euripides90]

With Galena management putting all their eggs in the Neuvax basket including selling off revenue-producing product to expedite taking this to market it was a shock to many who likewise put their eggs in the GALE basket -- even thought here were signs management is careless... however Neuvax in combo with Herceptin is another matter, Roche is behind that study and has an incentive to push that to market since its patent on Herceptin is coming to an end, that is one way to carry on the value --

and Schwarz did sell his last company to Roche as well, there are many links including location of choice...

Trials being done by Roche aren't like those in India that possibly didn't meet the same standards or so the rumor mill has it...

Neuvax for gastric cancer is being studied...

There are the GALE 301-02 products that have significant value...

And we'll see what Galena finds in its unblinded review.

Somehow I feel there's a lot more here than meets the eye and it's not so dire, the market seems to feel similarly --

of course the plunge is worse than the worst roller-coaster literally stomach-churning to lose 1/2 - 3/4 of one's nest egg
...but the PPS should have been much higher to start with on assumption of Neuvax's success so it's not surprising it holds and rises...

Hoping for a more satisfactory explanation of the results since it defies logic that after all the earlier trials Neuvax was futile.